SUNPHARMA:NSE
Sun Pharmaceutical Industries Ltd
₹ 1,746.40
arrow_downward
-1.37%(-24.30) 1D
10-р сарын 14, 15:30:00 (GMT+5:30) · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SUNPHARMA...
Open
₹ 1,770.10
High
₹ 1,770.10
Low
₹ 1,725.50
Mkt. cap
4.19ИН
Avg. vol.
1.60 сая
Volume
1.81 сая
Dividend
0.92%
Quarterly dividend
₹ 4.00
Ex-dividend date
2026 оны 7-р сарын 7
P/E ratio
34.62
52-wk high
₹ 2,046.90
52-wk low
₹ 1,583.70
EPS
₹ 50.44
Shares outstanding
0.00
No. of employees
47 мян
Open
₹ 1,770.10
High
₹ 1,770.10
Low
₹ 1,725.50
Mkt. cap
4.19ИН
Avg. vol.
1.60 сая
Volume
1.81 сая
Dividend
0.92%
Quarterly dividend
₹ 4.00
Ex-dividend date
2026 оны 7-р сарын 7
P/E ratio
34.62
52-wk high
₹ 2,046.90
52-wk low
₹ 1,583.70
EPS
₹ 50.44
Shares outstanding
0.00
No. of employees
47 мян
News stories
From web sources and news partners
ad-hoc-news.de
·
1 өдрийн өмнө
Geojit raises target for Sun Pharma stock to INR 2,070.00
TipRanks
·
2 өдрийн өмнө
Sun Pharma Clears INR 10,000 Crore NCD Plan as Independent Director Resigns
TipRanks
·
2 өдрийн өмнө
Sun Pharma Plans Up to INR 10,000 Crore NCD Issue as Independent Director Resigns
ad-hoc-news.de
·
2 өдрийн өмнө
Sun Pharma stock at INR 1,760.00, 14.0 percent below high on October 9, 2026
Profile
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
About Sun Pharmaceutical Industries Ltd
CEO-
Employees47 мян
Founded1983
HeadquartersGoregaon East, Мумбай, Энэтхэг
SectorPharmaceutical industry
Websitesunpharma.com